+91 780-304-0404

Insulin Delivery Devices Market

Global Insulin Delivery Devices Market Size, Share & Trends Analysis Report, By Type (Insulin Syringes, Insulin Pens, Insulin Jet Injectors, and Insulin Pumps), By End-User (Hospitals & Clinics and Homecare), and Forecast 2019-2025

Published: Nov 2019 | Report Code: | Category : Medical Devices | Delivery Format: /

The global insulin delivery devices market is projected to grow at a CAGR of 8.7% during 2019-2025. Various pivotal factors are boosting the market growth such as rising incidence and prevalence rate of diabetes, increasing awareness among the population towards diabetes and availability of a variety of insulin delivery devices in the market. Insulin is a necessary element required for the treatment of diabetes patients. Insulin enables a person’s body to use glucose from carbohydrates in the food consumed by the patient for future use.

Rising diabetes patients are considered to be a key driver in the growth of the global insulin delivery devices market. According to the International Diabetes Federation (IDF), around 425 million people had diabetes across the globe in 2017, and this number is further estimated to rise to 6 million by 2045. This significant increase in the diabetes population will increase the demand for insulin, which in turn, will spur the growth of the global insulin delivery devices industry in the near future.

Additionally, government support and their reimbursement policies in some countries such as the US are positively driving the market growth. The federal government offers financial support to diabetes patients by providing them various health insurance. Medicare, the Children's Health Insurance Program (CHIP), TRICARE, and veterans' health care programs are some programs that support patients. Moreover, some acts such as the Affordable Care Act (ACA) prevents insurers from denying coverage or charging higher premiums to people with preexisting conditions, such as diabetes are also fueling the market considerably. The features of insulin delivery devices including its accuracy, efficiency, and cost-effectiveness attract customers from different regions and thus drive market growth. 

However, there is a lack of reimbursement policies in some emerging economies such as Bulgaria; the Czech Republic and others which do not give so much priority to diabetes. In addition to policies, the risk of infections associated with some devices such as insulin pens and syringes acts as a restraint for the market. The adoption of oral insulin as an alternative to these devices, which is negatively impacting the growth of the insulin delivery devices market. Besides, technological advancement and innovations to prevent diabetes and the significant rise in the amount of spending on diabetes are expected to create opportunities in the near future.

Segmental Outlook  

The global insulin delivery devices market is segmented on the basis of type and end-user. Based on the end-user, the homecare usage segment held the major market share in 2018. Easy and convenient usage of these devices at home is anticipated to boost the segmental growth of the market during the forecast period. Based on type, the global insulin delivery devices market is segmented into insulin syringes, insulin pens, insulin jet injectors, and insulin pumps. Insulin pumps are anticipated to exhibit considerable growth during the forecast period owing to the introduction of advanced insulin devices such as portable insulin pumps.

Global Insulin Delivery Devices Market Share by Type, 2018 (%)

Global Insulin Delivery Devices Market Share by Type

Regional Outlook 

The global insulin delivery devices market is further segmented on the basis of geography into North America, Europe, Asia-Pacific and Rest of the World. The supportive government policies and the high adoption of insulin delivery devices make North America a major region in the insulin delivery devices industry with the US being the major contributor. According to the Centers for Disease Control and Prevention (CDC), 30.3 million people in the US had diabetes in 2017; among them, 23.1 million people were diagnosed, and 7.2 million patients remained undiagnosed. Thus, a high prevalence of diabetes and a high diagnosis rate through easy accessibility of technologically advanced devices are further fueling the regional growth of the market. North America is followed by Europe, while the Asia-Pacific is projected to be the fastest-growing market during the forecasted period.

Global Insulin Delivery Devices Market Growth, by Region 2019-2025

Global Insulin Delivery Devices Market Growth, by Region

Asia-Pacific will augment with the significant growth rate in insulin delivery devices market 

Asia-Pacific is anticipated to show significant growth during the forecast period. According to IDF,  around 114 million people in China and around 72 million people in India had diabetes in 2017. The increasing number of diabetes patients in emerging countries of Asia-Pacific region such as China, India, and Japan creates demand for insulin delivery devices, thus contributing to the growth of insulin delivery devices in the market. Additionally, growing awareness of diabetes management and treatment in emerging nations of Asia-Pacific is estimated to boost the insulin delivery devices industry in the region.  

Market Players Outlook

Some of the key players operating in the market include Novo Nordisk A/S, Eli Lilly and Co., Sanofi SA, Becton, Dickinson, and Co., and Medtronic PLC. Merger & acquisition, product launch, investment in R&D, strategic alliances, and partnerships are the key growth strategies adopted by the key market players. For Instance, in February 2019, the US Food and Drug Administration announced the approval of Tandem Diabetes Care’s t: slim X2 pumps. These pumps can make a reliable and secure communication with digitally connected devices such as insulin dosing software, to receive, execute, and confirm command from these devices.  

The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global insulin delivery devices market. Based on the availability of data, information related to products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary 

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Novo Nordisk A/S

3.3.1.1. Overview

3.3.1.2. Financial Analysis

3.3.1.3. SWOT Analysis

3.3.1.4. Recent Development

3.3.2. Eli Lilly and Co.

3.3.2.1. Overview

3.3.2.2. Financial Analysis

3.3.2.3. SWOT Analysis

3.3.2.4. Recent Developments

3.3.3. Sanofi SA

3.3.3.1. Overview

3.3.3.2. Financial Analysis

3.3.3.3. SWOT Analysis

3.3.3.4. Recent Developments

3.3.4. Becton Dickinson, and Co.

3.3.4.1. Overview

3.3.4.2. Financial Analysis

3.3.4.3. SWOT Analysis

3.3.4.4. Recent Developments

3.3.5. Medtronic PLC

3.3.5.1. Overview

3.3.5.2. Financial Analysis

3.3.5.3. SWOT Analysis

3.3.5.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Global Insulin Delivery Devices Market by Type 

5.1.1. Insulin Syringes

5.1.2. Insulin Pens

5.1.3. Insulin Jet Injectors

5.1.4. Insulin Pumps

5.2. Global Insulin Delivery Devices Market by End-User

5.2.1. Hospitals & Clinics

5.2.2. Homecare 

6. Regional Analysis

6.1. North America

6.1.1. US

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. Rest of Asia-Pacific

6.4. Rest of the World

7. Company Profiles

7.1. Animas LLC

7.2. Abbott Laboratories, Inc.

7.3. B. Braun Melsungen AG

7.4. Becton, Dickinson and Co.

7.5. Bigfoot Biomedical Inc.

7.6. Biocon Ltd.

7.7. Eli Lilly and Co.

7.8. F. Hoffmann-La Roche AG

7.9. Gerresheimer AG

7.10. Insulet Corp.

7.11. Julphar

7.12. MannKind Corp.

7.13. Medtronic PLC

7.14. Novo Nordisk A/S

7.15. Sanofi SA

7.16. SciGen Pte Ltd.

7.17. Tandem Diabetes Care, Inc.

7.18. Valeritas Holdings, Inc.

7.19. Wockhardt Ltd.

7.20. Ypsomed AG

1. GLOBAL INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

2. GLOBAL INSULIN SYRINGES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL INSULIN PENS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL  INSULIN JET INJECTORS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL INSULIN PUMPS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

7. GLOBAL INSULIN DELIVERY DEVICES IN HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL INSULIN DELIVERY DEVICES IN HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

9. GLOBAL INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

10. NORTH AMERICAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

11. NORTH AMERICAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

12. NORTH AMERICAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

13. EUROPEAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

14. EUROPEAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

15. EUROPEAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

16. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

17. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

18. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

19. REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

20. REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

1. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE BY TYPE, 2018 VS 2025 (%)

2. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE BY END-USER, 2018 VS 2025 (%)

3. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. US INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

6. UK INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

10. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

11. ROE INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

12. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

13. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

14. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2025 ($ MILLION)

Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports